Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-06-10
著者
-
Schlitt Hans
Department Of Surgery University Of Regensburg
-
Scheneider Anneliese
Antisense Pharma Gmbh University Medical Center Regensburg
-
SCHLINGENSIEPEN Karl-Hermann
Antisense Pharma GmbH, University Medical Center Regensburg
-
JASCHINSKI Frank
Antisense Pharma GmbH, University Medical Center Regensburg
-
LANG Sven
Department of Surgery, University Medical Center Regensburg
-
MOSER Christian
Department of Surgery, University Medical Center Regensburg
-
GEISSLER Edward
Department of Surgery, University Medical Center Regensburg
-
KIELMANOWICZ Marcus
Antisense Pharma GmbH, University Medical Center Regensburg
-
Lang Sven
Department Of Surgery University Medical Center Regensburg
-
Geissler Edward
Department Of Surgery University Medical Center Regensburg
-
Moser Christian
Department Of Surgery University Medical Center Regensburg
-
Kielmanowicz Marcus
Antisense Pharma Gmbh University Medical Center Regensburg
-
Schlingensiepen Karl-hermann
Antisense Pharma Gmbh University Medical Center Regensburg
-
Schlitt Hans
Department Of Surgery University Medical Center Regensburg
-
Jaschinski Frank
Antisense Pharma Gmbh University Medical Center Regensburg
関連論文
- Surgical Treatment of Substernal Goiter : An Analysis of 59 Patients
- Effectiveness of Peripheral Hepatogastrostomy Versus Hepatojejunostomy in the Treatment of Obstructive Cholestasis : Results of an Experimental Model
- Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer